Caribou Biosciences, Inc. Common Stock (CRBU) — Analysis Summary
Caribou Biosciences, Inc. Common Stock (CRBU) has a market cap of $234.07M with year-over-year revenue growth of +11.7%. Net margin stands at -1327.4%. The stock trades at a P/E ratio of -1.8.
Key Takeaways
- Revenue changed +11.7% year-over-year
- Net margin of -1327.4%
- P/E ratio of -1.8
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, CRBU posted revenue growth of +11.7% and trades at a P/E of -1.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.